Biologic Solutions

Auxergen At A Glance

Countries
0
Patents
0
Technologies
0
Markets Targeted
$ 0 B
Peer Reviewed Papers
0

XylePhage, treatment for Xylella fastidiosa

Recent Press

Research at Auxergen Reveals Secrets of Virus Assembly

Baltimore, Maryland – November 3, 2024 Unlocking the Secrets of Virus Assembly: A Breakthrough at Auxergen Exciting News! Auxergen has just published groundbreaking research in the journal Virology, revealing the secrets of virus assembly. Our study on Xanthomonas integrative filamentous phages uncovers

Read More »

About Us

Auxergen creates and sells innovative biocontrol solutions that tackle diseases impacting humans, plants, and the environment; our mission is to substantially reduce the chemical strain on our soils and waterways.

Recognized as a Qualified Maryland Biotechnology Company by the Maryland Department of Commerce, we are one of the most widely published companies in ag-bio in America and foster a fertile ground for biotechnological advancements. Maryland has recognized our value year after year as a QMBC, enabling our investors to receive tax incentives for investing in Auxergen and, thereby, propelling Maryland towards a more prosperous, sustainable future.

Our Products & Technologies

Work With Us

Working with Auxergen is an opportunity to fuel genuine advancements addressing global challenges in agriculture and the environment. Our work fosters the development of sustainable solutions with substantial returns driven by market demands and groundbreaking innovations.

Call Us

443.887.4110

Mail Us

info@auxergen.com